Moraya, Amani Ali, Jennifer Samadder, Pranati Liang, Lisa Morrison, Ludivine Werbowetski-Ogilvie, Tamra Ogunsina, Makanjuola Schweizer, Frank Arthur, Gilbert Nachtigal, Mark Additional file 3: Figure S2 a. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells Images of ovarian cancer cell clusters present in ascites fluid from patients EOC174 and EOC189. EOC174 had a larger number of cell clusters and larger clusters resembling spheroids. b. Representative images of EOC cells (A2780-cp cell line or primary cell samples EOC140 and EOC146) grown as adherent monolayers, non-adherent aggregates or spheroids at 2 and 7 days after seeding ultralow attachment plates. EOC140 are capable of forming spheroids by 7 days after seeding, whereas EOC146 formed numerous spheroid structures within 2 days. Ovarian cancer;Drug-resistance;Glycosylated anti-tumour ether lipid;Spheroid 2017-05-12
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_Figure_S2_a_of_Novel_glycolipid_agents_for_killing_cisplatin-resistant_human_epithelial_ovarian_cancer_cells/5004290
10.6084/m9.figshare.c.3778562_D3.v1